Clinical Trial

A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants

Name: A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants — clinical trial record (NCT07421778)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

QRL-101-08 is a multiple ascending dose (MAD) study to evaluate the safety, tolerability, and pharmacokinetics (PK) of a novel formulation of QRL-101 in healthy participants.

Protocol Amendment History 1 change

critical Enrollment closed, study ongoing 2026-08-12

Trial Details

NCT Number	NCT07421778
Lead Sponsor	QurAlis Corporation
Conditions	Healthy Participant Study
Enrollment	48 participants
Start Date	2026-02-02
Primary Completion	2026-08-31 (estimated)
Study Completion	2026-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-11